These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16461236)

  • 1. Antibodies to hepatitis C and other viral markersin multi-transfused patients from Argentina.
    Remesar M; Gamba C; Kuperman S; Marcosa MA; Miguez G; Caldarola S; Pérez-Bianco R; Manterola A; Del Pozo A
    J Clin Virol; 2005 Dec; 34 Suppl 2():S20-6. PubMed ID: 16461236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-transmitted infections inmulti-transfused patients in Honduras.
    Vinelli E; Lorenzana I
    J Clin Virol; 2005 Dec; 34 Suppl 2():S53-60. PubMed ID: 16461241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay.
    López L; López P; Arago A; Rodríguez I; López J; Lima E; Insagaray J; Bentancor N
    J Clin Virol; 2005 Dec; 34 Suppl 2():S69-74. PubMed ID: 16461243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban patients.
    Ballester JM; Rivero RA; Villaescusa R; Merlín JC; Arce AA; Castillo D; Lam RM; Ballester A; Almaguer M; Melians SM; Aparicio JL
    J Clin Virol; 2005 Dec; 34 Suppl 2():S39-46. PubMed ID: 16461239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru.
    Laguna-Torres VA; Pérez-Bao J; Chauca G; Sovero M; Blichtein D; Chunga A; Flores W; Retamal A; Mendoza S; Cruz M; Monge Z; Lavalle M; Gutiérrez J; Málaga J; Soto E; Loayza N; Bolívar D; Reyna R; Mendoza C; Oré M; González J; Suárez M; Montano SM; Sánchez JL; Sateren W; Bautista CT; Olson JG; Xueref S
    J Clin Virol; 2005 Dec; 34 Suppl 2():S61-8. PubMed ID: 16461242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-transmitted infections among multi-transfused patients in Brazil.
    de Paula EV; Gonçales NS; Xueref S; Addas-Carvalho M; Gilli SC; Angerami RN; Veríssimo MP; Gonçales FL
    J Clin Virol; 2005 Dec; 34 Suppl 2():S27-32. PubMed ID: 16461237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.
    Cruz JR; Pérez-Rosales MD; Zicker F; Schmunis GA
    J Clin Virol; 2005 Dec; 34 Suppl 2():S75-80. PubMed ID: 16461244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients.
    Ansari SH; Shamsi TS; Khan MT; Perveen K; Farzana T; Erum S; Ansari I
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):610-1. PubMed ID: 22980623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.
    Amarapurkar DN; Kumar A; Vaidya S; Murti P; Bichile SK; Kalro RH; Desai HG
    Indian J Gastroenterol; 1992 Apr; 11(2):80-1. PubMed ID: 1428037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
    de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
    Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections with HBV, HCV and HIV in patients admitted to the neurosurgical department of a teaching hospital.
    Gańczak M; Szych Z
    Neurol Neurochir Pol; 2008; 42(3):231-7. PubMed ID: 18651329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia.
    Tiruneh M
    Ethiop Med J; 2008 Oct; 46(4):359-66. PubMed ID: 19271400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.
    Flores GL; de Almeida AJ; Miguel JC; Cruz HM; Portilho MM; Scalioni Lde P; Marques VA; Lewis-Ximenez LL; Lampe E; Villar LM
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26978383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroprevalence of viral markers among blood donors at the Blood Donor Center of Mohammed V Military Teaching Hospital of Rabat, Morocco].
    Uwingabiye J; Zahid H; Unyendje L; Hadef R
    Pan Afr Med J; 2016; 25():185. PubMed ID: 28292147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].
    Gańczak M; Bohatyrewicz A; Szych Z; Białecki P
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(2):83-8. PubMed ID: 18846999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.